vimarsana.com
Home
Live Updates
Third Generation CAR T Cell Study Supports Use Of BioOra's A
Third Generation CAR T Cell Study Supports Use Of BioOra's A
Third Generation CAR T Cell Study Supports Use Of BioOra's Automated Manufacture For Phase 2 Trial
BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego.
Related Keywords
San Diego ,
California ,
United States ,
New Zealand ,
American ,
Rob Weinkove ,
Malaghan Institute Clinical ,
American Society Of Hematology ,
Malaghan Institute ,
Malaghan Institute Of Medical Research ,
Wellington Zhaotai Therapies Limited ,
Third Generation ,
Cell Study Supports Use Of Bioora ,
Automated Manufacture For Phase ,
Medical Research ,
American Society ,
Annual Meeting ,
Clinical Director ,
Principal Investigator ,
Carl June ,
Randi Grant ,
Bio Ora ,
Sci Tech ,
Medical ,
Ewsworthy ,
Scoop ,